Present relevant data about dose in patient: CDSCO Panel Tells Cipla on FDC of Torsemide Plus Spironolactone 5mg/25 mg Dr. Divya Colin30 March 2025 6:00 PM ISTNew Delhi: Citing that the data/literature presented by the drug major Cipla for the fixed-dose combination (FDC) drug Torsemide and Spironolactone (5...
Akum Drugs & Pharmaceutical gets CDSCO Panel nod for BE study of FDC Eplerenone plus Torsemide film-coated tablet Dr. Divya Colin8 Dec 2024 5:45 PM ISTNew Delhi: Akum Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Torsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngene's Proposal for BA/BE study Dr. Divya Colin25 Sept 2024 6:00 PM ISTNew Delhi: Noting the proposed fixed-dose combination (FDC) of 24 mg extended-release (ER) Torsemide and 8 mg Dapagliflozin Tablets is not rational;...
Synokem gets CDSCO Panel nod to study FDC Torsemide plus Eplerenone film coated tablet Dr. Divya Colin6 Feb 2024 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) report of the fixed-dose combination (FDC) Torsemide IP 10mg/ 20mg plus Eplerenone IP 25mg/25mg...
Conduct BE study with innovator drug as reference product: CDSCO Panel Tells Synokem on FDC Torsemide plus Eplerenone Dr. Divya Colin30 Dec 2023 5:45 PM ISTNew Delhi: After reviewing the bioequivalence (BE) study report presented by Synokem Pharmaceutical for the fixed-dose combination Torsemide IP...
Submit Revised protocol for Torsemide ER tablets: CDSCO Tells Syngene Dr. Divya Colin19 July 2023 6:00 PM ISTNew Delhi: Highlighting that proof of concept and criteria are not defined for the overactive bladder in Congestive heart failure (CHF) patients, the...
Torsemide and furosemide show no significant difference in all-cause mortality in HF patients: JAMA Dr. Mahalakshmi Sivashankaran28 March 2023 11:00 AM ISTUSA: A recent Clinical Trial called TRANSFORM-HF, published in JAMA, has found that torsemide and furosemide, two commonly used loop diuretics for...
Furosemide and torsemide equally effective in improving survival among patients with heart failure: JAMA Dr. Kamal Kant Kohli19 Jan 2023 11:15 AM ISTAccording to the Centers for Disease Control and Prevention, more than 6 million American adults live with heart failure.The condition is most common...
Torsemide does not confer any survival benefit over Furosemide in HF: TRANSFORM HF trial Dr.Niharika Harsha B7 Nov 2022 6:30 PM ISTResearchers have found in a new study that people treated with either loop diuretic medication furosemide or torsemide had similar death and...
Drug Safety Alert: Indian Pharmacopoeia Commission flags adverse reactions linked to Etoricoxib, others Medical Dialogues Team2 Aug 2021 6:28 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that certain...
